Anthem Biosciences Limited is bid farewell to a long-tenured member of its leadership as K. Ramakrishnan steps down from the role of General Counsel. The company informed the markets that Ramakrishnan will tender his resignation and will cease to hold the position at the close of business on March 31, 2026. Having joined the organization in 2007, Ramakrishnan served as a stable fixture in the legal and governance framework as Anthem navigated its growth and strategic ambitions.
The disclosure notes that Ramakrishnan was appointed General Counsel and, at a recent board meeting on November 5, 2024, was designated a member of the Senior Management Personnel. His decision to vacate the post is described in the context of superannuation, with his cessation from the role also ending his status as a member of senior management. While the company has attached the resignation letter as Annexure B and has published the disclosure on its investor portal, it has not specified a successor at this time.
As Anthem prepares for a leadership transition in its legal function, governance and risk oversight considerations will come under renewed focus. The organization’s forthcoming steps to identify and onboard a successor will be watched closely by investors and stakeholders as the company continues to steer its governance framework through an era of ongoing transformation.
This development underscores the lasting influence of long-serving senior leaders and the ongoing need for seamless continuity in the company’s legal and compliance capabilities as Anthem progresses on its strategic journey.